Cargando…
Hypothalamic‐pituitary‐adrenal axis and depression symptom effects of an arginine vasopressin type 1B receptor antagonist in a one‐week randomized Phase 1b trial
BACKGROUND: Arginine vasopressin 1B receptor (V(1B)) antagonists may have utility for the treatment of major depressive disorder (MDD). METHODS: The V(1B) antagonist ABT‐436 (N = 31) or matching placebo (N = 20) was administered to MDD subjects for 7 days. The main study objectives were to assess th...
Autores principales: | Katz, David A., Locke, Charles, Greco, Nicholas, Liu, Wei, Tracy, Katherine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346517/ https://www.ncbi.nlm.nih.gov/pubmed/28293470 http://dx.doi.org/10.1002/brb3.628 |
Ejemplares similares
-
Arginine Vasopressin and Arginine Vasopressin Receptor 1b Involved in Electroacupuncture‐Attenuated Hypothalamic‐Pituitary‐Adrenal Axis Hyperactivity in Hepatectomy Rats
por: Zhu, Jing, et al.
Publicado: (2015) -
Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis
por: Stojiljković, Aleksandra S., et al.
Publicado: (2022) -
Methamphetamine and the hypothalamic-pituitary-adrenal axis
por: Zuloaga, Damian G., et al.
Publicado: (2015) -
Erratum on: Methamphetamine and the hypothalamic-pituitary-adrenal axis
Publicado: (2015) -
The effects of apelin on hypothalamic–pituitary–adrenal axis neuroendocrine function are mediated through corticotrophin-releasing factor- and vasopressin-dependent mechanisms
por: Newson, Michael J F, et al.
Publicado: (2009)